Welcome to our dedicated page for 908 Devices news (Ticker: MASS), a resource for investors and traders seeking the latest updates and insights on 908 Devices stock.
908 Devices Inc. (MASS) delivers innovative mass spectrometry solutions enabling real-time chemical analysis across safety, life sciences, and industrial sectors. This news hub provides investors and professionals with essential updates on corporate developments and technological advancements.
Access timely press releases, earnings reports, and strategic announcements in one centralized location. Our curated collection includes regulatory filings, product launch details, and partnership updates critical for understanding the company's market position.
Key updates cover:
- Financial performance and investor communications
- Breakthroughs in handheld/desktop analysis devices
- Industry-specific applications in biotech and forensics
- Global expansion initiatives and regulatory milestones
Bookmark this page for streamlined access to MASS's evolving story. Combine our news archive with SEC filings and market analysis tools for comprehensive due diligence.
908 Devices Inc (NASDAQ: MASS) announced that National Resilience, Inc. has adopted its REBEL at-line media analyzers, enhancing the optimization of cell culture feed strategies. This partnership aims to improve biotherapeutic development by utilizing REBEL to analyze spent media samples, resulting in a reported 50% increase in titer while reducing costs by supplementing only depleted nutrients. Andy Grube from Resilience highlighted the tool's capability to accelerate media feed optimization and reduce time to submission. The REBEL analyzer is noted for its efficiency, real-time data tracking of key nutrients, and user-friendly design, facilitating better decisions during bioreactor runs.
908 Devices (NASDAQ: MASS) announced it will reveal its financial results for the first quarter 2023 on May 9, 2023, before market open. A conference call will follow at 5:30 a.m. PT / 8:30 a.m. ET, available via a webcast on the company’s website. The webcast will also be archived for playback within 24 hours post-event.
The company specializes in handheld and desktop devices for chemical and biochemical analysis, significantly impacting life sciences, bioprocessing, pharma/biopharma, and forensics. The innovative technology employs mass spectrometry and machine learning for rapid, actionable insights.
FAQ
What is the current stock price of 908 Devices (MASS)?
What is the market cap of 908 Devices (MASS)?
